19/01/2013 00:27:00

Johnson & Johnson in Talks for Hip Implant Settlement -Bloomberg

Related content

Johnson & Johnson (JNJ) is in talks to settle litigation over recalled hip implants, Bloomberg News reported Friday, citing five people familiar with the matter.

The settlement could total more than $2 billion if most plaintiffs accept the terms, Bloomberg reported.

According to the report, J&J has offered to pay more than $200,000 per case, while lawyers for plaintiffs have said the offer is too low.

Full story at http://www.bloomberg.com/news/2013-01-18/j-j-said-to-offer-implant-pact-that-may-reach-2-billion.html

Write to nymonitoring@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

(END) Dow Jones Newswires

January 18, 2013 19:27 ET (00:27 GMT)

Copyright (c) 2013 Dow Jones & Company, Inc.

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

Regulatory news

Alliance Trust PLC : Net Asset Value(s)

26/07/2017 12:50:03
ALLIANCE TRUST PLC                                    At the close of business on Tuesday 25 July 2017: The Company's NAV per ordinary share, valued on a bid price basis with Debt at Par, was -       excluding income, 759.9p -       including income, 768.5p  The Company's NAV per ordinary share, valued on a bid price basis with Debt at Fair Value, was -       excluding income..

Form 8.5 (EPT/RI) - Tesco plc

26/07/2017 09:43:41
FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY 1.         KEY INFORMATION (a) Name of exempt principal trader:   Investec Bank plc   (b) Name of offeror/offeree in relation to whose relevant se..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
ATOS : First half 2017 results
2
Columbia University Medical Center’s Center for Biomedical Informatics Collaborates with Admera Health in a Clinical Study, Evaluating Pharmacogenetics in Psychiatric Medications
3
Santen and TRACON Announce Initiation of a Phase 2a Study of DE-122 for the Treatment of Wet Age-Related Macular Degeneration
4
STMicroelectronics Reports 2017 Second Quarter and First Half Financial Results
5
Timberland Bank Reports Growing Profitability for 2017’s Third Fiscal Quarter:

Related stock quotes

Johnson & Johnson 130.97 -0.7% Stock price decreasing

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Euroinvestor A/S 2017   Disclaimer and Terms of Use
Quote information is delivered by Interactive Data.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
26 July 2017 17:29:25
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20170720.2 - EUROWEB6 - 2017-07-26 18:29:25 - 2017-07-26 17:29:25 - 1000 - Website: OKAY